Case-control study of bladder cancer and arsenic in drinking water
- PMID: 7900719
- DOI: 10.1093/oxfordjournals.aje.a117467
Case-control study of bladder cancer and arsenic in drinking water
Abstract
Mortality from several cancers, including bladder cancer, is elevated in a Taiwanese population exposed to high levels of arsenic in drinking water. Data from the Utah respondents to the National Bladder Cancer Study conducted in 1978 were used to evaluate these associations in a US population exposed to measurable, but much lower, levels of drinking water arsenic. Two indices of cumulative arsenic exposure were used, one representing total cumulative exposure (index 1) and the other, intake concentration (index 2). Overall, there was no association of bladder cancer with either measure; however, among smokers, but not among nonsmokers, positive trends in risk were found for exposures estimated for decade-long time periods, especially in the 30- to 39-year period prior to diagnosis. Exposures were in the range 0.5-160 micrograms/liter (mean, 5.0 micrograms/liter). The data raise the possibility that smoking potentiates the effect of arsenic on risk of bladder cancer. However, the risk estimates obtained are much higher than predicted on the basis of the results of the Taiwanese studies, raising concerns about bias or the role of chance. Confirmatory studies are needed.
Similar articles
-
Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.Am J Epidemiol. 1998 Apr 1;147(7):660-9. doi: 10.1093/oxfordjournals.aje.a009507. Am J Epidemiol. 1998. PMID: 9554605
-
Case-control study of bladder cancer and exposure to arsenic in Argentina.Am J Epidemiol. 2004 Feb 15;159(4):381-9. doi: 10.1093/aje/kwh054. Am J Epidemiol. 2004. PMID: 14769642
-
Potential effect modifiers of the arsenic-bladder cancer risk relationship.Int J Cancer. 2018 Dec 1;143(11):2640-2646. doi: 10.1002/ijc.31720. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 29981168 Free PMC article.
-
Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.Toxicology. 2014 Mar 20;317:17-30. doi: 10.1016/j.tox.2014.01.004. Epub 2014 Jan 21. Toxicology. 2014. PMID: 24462659 Review.
-
Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity.J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):223-34. doi: 10.1080/15287399309531790. J Toxicol Environ Health. 1993. PMID: 8230298 Review.
Cited by
-
Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.Environ Health. 2012 Jun 29;11:43. doi: 10.1186/1476-069X-11-43. Environ Health. 2012. PMID: 22747749 Free PMC article.
-
Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease.BJU Int. 2012 Jan;109(1):52-6. doi: 10.1111/j.1464-410X.2011.10283.x. Epub 2011 May 18. BJU Int. 2012. PMID: 21592300 Free PMC article.
-
Bladder cancer mortality and private well use in New England: an ecological study.J Epidemiol Community Health. 2006 Feb;60(2):168-72. doi: 10.1136/jech.2005.038620. J Epidemiol Community Health. 2006. PMID: 16415269 Free PMC article.
-
Mechanisms pertaining to arsenic toxicity.Toxicol Int. 2011 Jul;18(2):87-93. doi: 10.4103/0971-6580.84258. Toxicol Int. 2011. PMID: 21976811 Free PMC article.
-
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?Curr Diab Rep. 2017 Mar;17(3):18. doi: 10.1007/s11892-017-0845-8. Curr Diab Rep. 2017. PMID: 28275977 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical